In patients with HER2-enriched breast cancer with brain metastasis, the upregulation of xCT (SLC7A11), a cystine/glutamate antiporter facilitating cystine import and glutamate export, was observed (Parida et al., 2022). The gene discussed is SLC7A11; the disease is breast cancer.